Cat. No.: DAB-0010960
Product Information | |
---|---|
Clonality | Monoclonal |
Isotype | IgG1 |
Host Species | Mouse |
Reactivity | Human, Mouse, Cynomolgus monkey |
Applications | WB |
Product Description | Mouse monoclonal antibody [ABM4F71] to E3 ubiquitin-protein ligase MUL1 - C-terminal. |
Format | Liquid |
Purity | Affinity purity |
Target Information | |
---|---|
Target Name | MUL1 |
UniProt No. | Q969V5 |
Gene ID | 79594 |
Gene Description | Exhibits weak E3 ubiquitin-protein ligase activity, but preferentially acts as a SUMO E3 ligase at physiological concentrations. Plays a role in the control of mitochondrial morphology. Promotes mitochondrial fragmentation and influences mitochondrial localization. Inhibits cell growth. When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. |
Shipping & Storage | |
---|---|
Shipping | Shipped at 4 °C. |
Storage Instructions | Store at +4 °C short term (1-2 weeks). Upon delivery aliquot. Store at -20 °C long term. Avoid freeze / thaw cycle. |
Storage Buffer | Preservative: 0.05% Sodium azide; Constituents: 99% PBS, 0.05% BSA |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.